S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
NASDAQ:OM

Outset Medical (OM) Stock Price, News & Analysis

$3.09
-0.06 (-1.90%)
(As of 03/1/2024 ET)
Today's Range
$3.00
$3.20
50-Day Range
$2.95
$5.67
52-Week Range
$2.73
$24.13
Volume
601,578 shs
Average Volume
939,385 shs
Market Capitalization
$156.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.13

Outset Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
65.9% Upside
$5.13 Price Target
Short Interest
Bearish
15.88% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.60mentions of Outset Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$648,452 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.28) to ($2.23) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.50 out of 5 stars

Medical Sector

808th out of 957 stocks

Electromedical Equipment Industry

18th out of 20 stocks


OM stock logo

About Outset Medical Stock (NASDAQ:OM)

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Stock Price History

OM Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Q4 2023 Outset Medical Inc Earnings Call
Rare Earth Elements: The Workhorse of The Tech Revolution
They're the most underrated yet crucial elements of technology. From renewable energy to military defense, Rare Earths are essential pieces of modern technology. Global superpowers and savvy investors are quickly learning just how valuable they truly are.
Outset Medical Q4 2023 Earnings Preview
OM Mar 2024 4.000 put
Outset Medical Inc (OM)
OM May 2024 10.000 call
OM Feb 2024 10.000 put
5 Analysts Have This to Say About Outset Medical
Outset Medical to Present at BofA Home Care Conference
See More Headlines
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/12/2023
Today
3/01/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Fax
N/A
Employees
518
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.13
High Stock Price Target
$6.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+65.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-172,800,000.00
Net Margins
-132.54%
Pretax Margin
-132.14%

Debt

Sales & Book Value

Annual Sales
$130.38 million
Book Value
$2.43 per share

Miscellaneous

Free Float
48,637,000
Market Cap
$156.08 million
Optionable
Not Optionable
Beta
2.05
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report














OM Stock Analysis - Frequently Asked Questions

Should I buy or sell Outset Medical stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares.
View OM analyst ratings
or view top-rated stocks.

What is Outset Medical's stock price target for 2024?

5 Wall Street research analysts have issued twelve-month price targets for Outset Medical's shares. Their OM share price targets range from $3.00 to $6.00. On average, they anticipate the company's share price to reach $5.13 in the next year. This suggests a possible upside of 65.9% from the stock's current price.
View analysts price targets for OM
or view top-rated stocks among Wall Street analysts.

How have OM shares performed in 2024?

Outset Medical's stock was trading at $5.41 on January 1st, 2024. Since then, OM stock has decreased by 42.9% and is now trading at $3.09.
View the best growth stocks for 2024 here
.

When is Outset Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our OM earnings forecast
.

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) announced its earnings results on Thursday, October, 12th. The company reported ($0.71) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.74) by $0.03. Outset Medical had a negative trailing twelve-month return on equity of 102.50% and a negative net margin of 132.54%.

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.8 million.

When did Outset Medical IPO?

(OM) raised $175 million in an initial public offering on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Who are Outset Medical's major shareholders?

Outset Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.85%), Bellevue Group AG (3.51%), Assenagon Asset Management S.A. (2.03%), PFM Health Sciences LP (1.99%), Fiera Capital Corp (1.09%) and GSA Capital Partners LLP (1.02%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Marc Nash, Martin Vazquez, Nabeel Ahmed, Rebecca Chambers, Stacey L Porter, Steven S Williamson and Warburg Pincus Llc.
View institutional ownership trends
.

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OM) was last updated on 3/1/2024 by MarketBeat.com Staff